If you have been reading about REV-ERB and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2025-11-20. Where a claim depends on a specific study, the study is described rather than over-claimed.
SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.
SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.
Mechanistically, SR9009 binds the ligand-binding domain of REV-ERBα/β and enhances recruitment of corepressor complexes. This represses target genes rather than activating them. Because REV-ERB proteins normally compete with ROR proteins at shared response elements, the net effect depends on tissue and timing. Researchers use SR9009 to probe how nuclear receptor signaling links the clock to metabolism, inflammation, and muscle biology. Findings are largely preclinical, and the precise contribution of each receptor subtype remains under study.
Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Small-molecule ligand; not a hormone or peptide |
| Molecular formula | C20H24ClN3O4S | Reported for the free base |
| CAS Registry Number | 1379686-30-2 | Unique chemical identifier |
| Common synonyms | SR9009; stenabolic | Stenabolic is informal and not an official name |
| Reported targets | REV-ERBα and REV-ERBβ | Nuclear receptors linked to circadian and metabolic regulation |
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.
SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
The bill to allow beer and wine sales in grocery stores was withdrawn by its sponsor, Cory McCray, moments before it was poised to be killed by the Senate Finance Committee, and its House crossfile never received a vote in the House Economic Matters Committee. As of 2025, Maryland is one of five states that do not allow alcohol sales except in liquor or packaged goods stores. During the 2026 legislative session, Moore introduced the DECADE Act, which extends initiatives for companies in tax-incentive zones and eliminates certain eligibility requirements for startup businesses to qualify for assistance programs, and another bill to ban surveillance pricing and dynamic pricing in grocery stores. Moore signed the dynamic pricing ban into law in April 2026.
Anti-aging creams are predominantly moisturizer-based skin care products marketed with unproven claims of making the consumer look younger by reducing, masking or preventing signs of skin aging such as wrinkles. In the United States, anti-aging products are commonly marketed with false health claims, and are deemed to be among various scams on consumers.
Tim Hortons, currently owned by Restaurant Brands International, opened its first store on May 17, 1964, in Hamilton, Ontario. It is the fourth largest publicly traded quick-service restaurant chain in North America based on market capitalization, and the largest in Canada. It has cornered the Canadian market for baked goods (76%) and coffee (62% compared to Starbucks, in the number two position, at 7%). The company has experienced substantial growth in the United States, where it has 613 stores (April 2011, about 220 more than it had in June 2008). It has a same-store sales growth rate of 3.9% in Canada and 4.9% in the US. The new partnership with Cold Stone Creamery helped push its US presence to over 600 stores. The partnership has since dissolved. Sales exceeded $2 billion in 2008. It was controlled by Wendy's International Inc. for 11 of the 46 years of operation, from August 8, 1995, until the end of 2006. On April 3, 2011, Tim Hortons oversaw 3,782 locations in North America 3,169 of which were in Canada. In the fourth quarter of 2010 Tim Hortons' profits were 27% more than they were over the entire 2009 fiscal year (for the quarter net income was up 314%). In Forbes' 2011 edition of the world's 2000 largest companies, Tim Hortons placed 1469th overall (up from 1714th in 2010) with annual sales of $2.6 billion (up from $2.014 billion in 2010), profits totalling $628 million (up from $280 million), assets worth $2.5 billion (up from $1.90 billion) and a market value of $7.5 billion (up from $5.41 billion).
A form of tofu may have been discovered during the Han dynasty (202 BC – AD 220), but it did not become a popular food in China until the Song dynasty (960–1279). In China, tofu was traditionally eaten at the graves of deceased relatives. Ghosts were said to have long since lost their chins and jaws, so only tofu was soft enough for them to eat. Before the advent of refrigeration in China, tofu was usually sold only in the winter because it did not spoil easily in cold weather. In the warmer months, once made, tofu would spoil if left for more than a day.
Sources: en.wikipedia.org
symporter Any of a class of transmembrane transporter proteins which facilitate the transport of two or more different molecules across the membrane at the same time and in the same direction; e.g. glucose and sodium ions. Contrast antiporter and uniporter.
A substrate (quartz, silicon, stainless steel, carbon fibers, etc.) is coated with a catalytic metal (Fe, Co, Ni) layer. Typically that layer is iron and is deposited via sputtering to a thickness of 1–5 nm. A 10–50 nm underlayer of alumina is often also put down on the substrate first. This imparts controllable wetting and good interfacial properties. When the substrate is heated to the growth temperature (~600 to 850 °C), the continuous iron film breaks up into small islands with each island then nucleating a carbon nanotube. The sputtered thickness controls the island size and this in turn determines the nanotube diameter. Thinner iron layers drive down the diameter of the islands and drive down the diameter of the nanotubes grown. The amount of time the metal island can sit at the growth temperature is limited as they are mobile and can merge into larger (but fewer) islands. Annealing at the growth temperature reduces the site density (number of CNT/mm2) while increasing the catalyst diameter. The as-prepared carbon nanotubes always have impurities such as other forms of carbon (amorphous carbon, fullerene, etc.) and non-carbonaceous impurities (metal used for catalyst). These impurities need to be removed to make use of the carbon nanotubes in applications.
An Oligopeptidase is an enzyme that cleaves peptides but not proteins. This property is due to its structure: the active site of this enzyme is located at the end of a narrow cavity which can only be reached by peptides.
For example, because of this trend in the sizes of orbitals, a large difference in atomic radii between the first and second members of each main group is seen in groups 1 and 13–17: it exists between neon and argon, and between helium and beryllium, but not between helium and neon. This similarly affects the noble gases' boiling points and solubilities in water, where helium is too close to neon, and the large difference characteristic between the first two elements of a group appears only between neon and argon. Moving helium to group 2 makes this trend consistent in groups 2 and 18 as well, by making helium the first group 2 element and neon the first group 18 element: both exhibit the characteristic properties of a kainosymmetric first element of a group. The group 18 placement of helium nonetheless remains near-universal due to its extreme inertness. Additionally, tables that float both hydrogen and helium outside all groups may rarely be encountered.
These antibiotics are regularly used in biological research as a selective pressure tool to promote plasmid expression. The strain referred to as Pf-CL145A has proved itself a promising solution for the control of invasive zebra mussels and quagga mussels (Dreissena). This bacterial strain is an environmental isolate capable of killing >90% of these mussels by intoxication (i.e., not infection), as a result of natural product(s) associated with their cell walls, and with dead Pf-145A cells killing the mussels equally as well as live cells. Following ingestion of the bacterial cells mussel death occurs following lysis and necrosis of the digestive gland and sloughing of stomach epithelium. Research to date indicates very high specificity to zebra and quagga mussels, with low risk of nontarget impact. Pf-CL145A has now been commercialized under the product name Zequanox, with dead bacterial cells as its active ingredient. Recent results showed the production of the phytohormone cytokinin by P. fluorescens strain G20-18 to be critical for its biocontrol activity by activating plant resistance.
Sources: en.wikipedia.org
SR9009 is a synthetic compound investigated as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is used in preclinical research on circadian rhythm and metabolism. It is not an approved drug.
No. It has no approved medical indication, and human safety and efficacy data are limited. It appears in research chemical markets and is banned by some sports authorities.
Natural ligands include heme and certain metabolites; SR9009 is a synthetic small molecule with higher potency and selectivity in some assays. Its effects depend on cell type and timing. It is not a naturally occurring compound.
Liquid chromatography–mass spectrometry is common for identity and purity checks. High-performance liquid chromatography with ultraviolet detection can also be used. Both methods require a suitable reference standard.